Showing results (131-140 of 192) with videos related to
Sort By:
Pageof 20
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 26, 1999
Impact of admission body weight and chemotherapy dose adjustment on the outcome of autologous bone marrow transplantationT M Dickson, C R Kusnierz-Glaz, K G Blume, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1991
Importance of bone marrow cytogenetic evaluation before autologous bone marrow transplantation for Hodgkin's diseaseN J Chao, A P Nademanee, G D Long, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1986
Bone marrow transplantation for hematologic malignancies in patients aged 30 years or olderK G Blume, S J Forman, A P Nademanee, et al.Blood|August 1, 1992
Dynamic assessment of quality of life after autologous bone marrow transplantationN J Chao, D K Tierney, J R Bloom, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 9, 2000
Four-cycle high-dose therapy with hematopoietic support for metastatic breast cancer: no improvement in outcomes compared with single-course high-dose therapyW W Hu, R S Negrin, K Stockerl-Goldstein, et al.Journal of the American Society of Nephrology : JASN|June 24, 2004
Acute renal failure after nonmyeloablative hematopoietic cell transplantationChirag R Parikh, Brenda M Sandmaier, Rainer F Storb, et al.Blood|April 1, 1987
Total body irradiation and high-dose etoposide: a new preparatory regimen for bone marrow transplantation in patients with advanced hematologic malignanciesK G Blume, S J Forman, M R O'Donnell, et al.Blood|August 9, 2003
Rituximab as adjuvant to high-dose therapy and autologous hematopoietic cell transplantation for aggressive non-Hodgkin lymphomaSteven M Horwitz, Robert S Negrin, Karl G Blume, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 21, 2006
High-dose carmustine, etoposide, and cyclophosphamide followed by allogeneic hematopoietic cell transplantation for non-Hodgkin lymphomaLisa Y Law, Sandra J Horning, Ruby M Wong, et al.Blood|August 1, 1987
Bone marrow transplantation for patients with Philadelphia chromosome-positive acute lymphoblastic leukemiaS J Forman, M R O'Donnell, A P Nademanee, et al.Pageof 20